[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100549183":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":11,"centralContacts":20,"locations":26,"responsibleParty":46,"collaborators":11,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":50,"sex":56,"minAge":57,"maxAge":11,"enrollmentInfo":58,"targetDuration":11,"studyType":61,"phases":62,"briefSummary":64,"conditions":65,"keywords":67,"overallStatus":29,"whyStopped":11,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":80},{"fullName":5,"class":6},"Centre Hospitalier Universitaire de Nice","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Treatment with paracetamol","EXPERIMENTAL",null,[13],"Drug: paracetamol administration",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":11},"DRUG","paracetamol administration","Patient hospitalized in Intensive Care Unit with a continuous measurement of blood pressure with a catheter and who have an administration of paracetamol by intravenous or per os",[9],[21],{"name":22,"role":23,"phone":24,"phoneExt":11,"email":25},"Kamila BURDZENIDZE, Study nurse","CONTACT","04 92 03 92 20","crc@chu-nice.fr",[27],{"facility":28,"status":29,"city":30,"state":11,"zip":31,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"CHU de NICE ARCHET","RECRUITING","Nice","06000","France","FR",{"type":35,"coordinates":36},"Point",[37,38],7.26608,43.70313,{"lat":38,"lon":37},[41,43],{"name":42,"role":23,"phone":24,"phoneExt":11,"email":25},"SACHA CARON, Study nurse",{"name":44,"role":45,"phone":11,"phoneExt":11,"email":11},"SACHA CARON","PRINCIPAL_INVESTIGATOR",{"type":47,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100549183","hemodynamic-impact-of-the-administration-of-paracetamol-in-patients-hospitalized-in-the-intensive-resuscitation-medicine-department-parea-100549183",false,"NCT06430697","Hemodynamic Impact of the Administration of PAracetamol in Patients Hospitalized in the Intensive Resuscitation Medicine Department [PAREA]","Prospective Study Evaluating the Hemodynamic Impact of PAracetamol Administration in Patients Hospitalized in the REAnimation Intensive Care Unit","PAREA","Inclusion Criteria:\n\nInclusion:\n\n* 18 years of age or older\n* Patient with arterial catheter\n* Indication of paracetamol's administration by the patient's attending practitioner.\n* No opposition to patient or support person participation in the study if the patient is unable to participate\n\nExclusionCriteria:\n\n* No Social Security Patient\n* Pregnant or nursing patient.\n* Patient with a legal protection measure\n* Hypersensitivity and\u002For allergy to paracetamol.\n* Contraindication to the use of paracetamol.\n* Patient opposition to health data collection.","ALL","18 Years",{"count":59,"type":60},200,"ESTIMATED","INTERVENTIONAL",[63],"NA","Paracetamol is commonly used in case of pain or fever. Few previously clinical studies has highlighted an arterial hypotension linked to intravenous administration of paracetamol. Currently, fewer data are available on the link of intravenous administration of paracetamol and effects on arterial tension. The aim of this study is to describe the frequency of occurrence of significative arterial hypotension within one hour following intravenous or per os administration of paracetamol . Other factors who can be associated to occurence of significative arterial hypotension will be also observe (for example age, weight, pain, vasopressor dosage or sedative...)",[66],"Intensive Care Unit Syndrome",[68,69,70],"Intensive Care Unit","PARACETAMOL","blood pressure","2026-05-21",{"date":73,"type":74},"2026-05-26","ACTUAL",{"date":76,"type":74},"2025-02-03",{"date":78,"type":60},"2028-09",{"name":5,"class":6},1]